galactosamine has been researched along with engeletin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Z; Shen, Z; Tian, Q; Wang, G; Yang, L; Zhang, F; Zhang, Y | 1 |
1 other study(ies) available for galactosamine and engeletin
| Article | Year |
|---|---|
Engeletin inhibits Lipopolysaccharide/d-galactosamine-induced liver injury in mice through activating PPAR-γ.
Topics: Animals; Chemical and Drug Induced Liver Injury; Flavonols; Galactosamine; Glycosides; Interleukin-1beta; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; NF-kappa B; PPAR gamma; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |